Hepatocyte Specific Antigen/Hep Par 1 – MMab

SKU: fd019869c6cf Categories: , , ,

Ihc Of Hepatocyte Specific Antigen On An Ffpe Liver Tissue

IHC of Hepatocyte Specific Antigen on an FFPE Liver Tissue

United States
Research Use
Safety Data Sheet
Intended UseFor In Vitro Diagnostic Use
Summary and ExplanationHepatocyte Specific Antigen (HSA or Hep Par 1) has been demonstrated consistently in the vast majority of Hepatocellular Carcinomas. Studies have shown the utility of HSA in the differential diagnosis of Hepatocellular Carcinoma, Cholangiocarcinoma and Hepatoblastomas. HSA recognizes both benign and malignant liver derived tissues including such tumors as Hepatoblastoma, Hepatocellular Carcinoma, and Hepatic Adenoma. It recognizes both normal adult and fetal liver tissue. The typical pattern is a granular cytoplasmic staining. This antibody is useful in differentiating Hepatocellular Carcinomas with adenoid features from Adenocarcinomas, either primary in the liver or metastatic lesions to the liver. In recognizing Hepatoblastoma, it is useful in differentiating this entity from other small round cell tumors.
Antibody TypeMouse MonoclonalCloneOCH1E5
IsotypeIgG1/KReactivityParaffin, Frozen
LocalizationCytoplasmicControlLiver, Liver Carcinoma
PresentationAnti-Hepatocyte Specific Antigen is a mouse monoclonal antibody derived from cell culture supernatant that is concentrated, dialyzed, filter sterilized and diluted in buffer pH 7.5, containing BSA and sodium azide as a preservative.
Catalog No.Antibody TypeDilutionVolume/QTY
BSB 5624PredilutedReady-To-Use3.0 ml
BSB 5625PredilutedReady-To-Use7.0 ml
BSB 5626PredilutedReady-To-Use15.0 ml
BSB 5627Concentrated1:100-1:5000.1 ml
BSB 5628Concentrated1:100-1:5000.5 ml
BSB 5629Concentrated1:100-1:5001.0 ml
BSB 5630Control Slides5
Note: For concentrated antibodies, please centrifuge prior to use to ensure recovery of all product.

Related products

Skip to content